SG Americas Securities »

Denali Therapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2023-09-30 $739k 36k 20.64
2023-06-30 $280k 9.5k 29.55
2023-03-31 $859k 37k 23.04
2022-12-31 $126k 4.5k 27.72
2022-09-30 $394k 13k 30.66
2022-06-30 $1.2M 39k 29.43
2022-03-31 $289k 9.0k 32.18
2021-12-31 $1.5M 33k 44.60
2021-09-30 $1.6M 31k 50.46
2021-06-30 $1.4M 17k 78.46
2021-03-31 $1.6M 27k 57.11
2020-12-31 $2.1M 26k 83.77
2020-09-30 $3.0M 83k 35.83
2020-06-30 $493k 20k 24.19
2020-03-31 $390k 22k 17.50
2019-12-31 $265k 15k 17.43
2019-09-30 $538k 35k 15.32
2019-06-30 $196k 9.4k 20.76
2019-03-31 $208k 9.0k 23.18